BE2014C050I2 - Circovirus sequences associated with piglet weight loss disease (PWD) - Google Patents

Circovirus sequences associated with piglet weight loss disease (PWD)

Info

Publication number: BE2014C050I2
Authority: BE; Belgium
Prior art keywords: pwd; circovirus; polypeptides; vectors; weight loss
Prior art date: 1997-12-05

Application number

BE2014C050C

Other languages

English (en)

French (fr)

Original Assignee

Zoetis Services Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-05

Filing date

2014-08-14

Publication date

2018-07-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9514225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2014C050(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-08-14 Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc

2018-07-04 Publication of BE2014C050I2 publication Critical patent/BE2014C050I2/fr

Links

241001533384 Circovirus Species 0.000 title abstract 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
208000016261 weight loss Diseases 0.000 title 1
230000004580 weight loss Effects 0.000 title 1
229920001184 polypeptide Polymers 0.000 abstract 3
102000004196 processed proteins & peptides Human genes 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
239000013598 vector Substances 0.000 abstract 3
208000036142 Viral infection Diseases 0.000 abstract 2
230000009385 viral infection Effects 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10051—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Tropical Medicine & Parasitology (AREA)
General Engineering & Computer Science (AREA)
Mycology (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)

BE2014C050C 1997-12-05 2014-08-14 Circovirus sequences associated with piglet weight loss disease (PWD) BE2014C050I2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9715396A FR2772047B1 (fr)	1997-12-05	1997-12-05	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
PCT/FR1998/002634 WO1999029871A2 (fr)	1997-12-05	1998-12-04	Sequences de circovirus associe a la maladie de l'amaigrissement du porcelet (map)

Publications (1)

Publication Number	Publication Date
BE2014C050I2 true BE2014C050I2 (en)	2018-07-04

Family

ID=9514225

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BE2014C049C BE2014C049I2 (en)	1997-12-05	2014-08-14	Circovirus sequences associated with piglet weight loss disease (PWD)
BE2014C050C BE2014C050I2 (en)	1997-12-05	2014-08-14	Circovirus sequences associated with piglet weight loss disease (PWD)

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
BE2014C049C BE2014C049I2 (en)	1997-12-05	2014-08-14	Circovirus sequences associated with piglet weight loss disease (PWD)

Country Status (15)

Country	Link
US (43)	US6703023B1 (da)
EP (6)	EP2316925B1 (da)
AT (1)	ATE412664T1 (da)
AU (1)	AU1491699A (da)
BE (2)	BE2014C049I2 (da)
CY (6)	CY1115405T1 (da)
DE (1)	DE69840174D1 (da)
DK (5)	DK2000535T3 (da)
ES (5)	ES2456959T3 (da)
FR (3)	FR2772047B1 (da)
HK (1)	HK1222415A1 (da)
LU (2)	LU92523I2 (da)
NL (2)	NL300686I2 (da)
PT (5)	PT1036180E (da)
WO (1)	WO1999029871A2 (da)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US7211379B2 (en)	1997-10-03	2007-05-01	Merial Sas	Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US6517843B1 (en)	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US7192594B2 (en)	1997-10-03	2007-03-20	Merial Limited	Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
AU2002302120B2 (en) *	1997-10-03	2006-01-19	Merial	Porcine circoviruses, vaccines and diagnostic reagents
AU2003248395B2 (en) *	1997-10-03	2006-03-16	Merial	Porcine CircoViruses, vaccines and diagnostic reagents
US6391314B1 (en)	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
EP1816200B1 (en) *	1997-12-11	2016-03-09	Merial	Postweaning multisystemic wasting syndrome virus for pigs
JP3795751B2 (ja)	1997-12-11	2006-07-12	ユニバーシティオブサスカッチェワン	ブタからの離乳後多全身系消耗症候群ウイルス
WO1999045956A1 (en) *	1998-03-13	1999-09-16	University Of Georgia Research Foundation, Inc.	Vaccines against circovirus infections
US6943152B1 (en) *	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
ES2170622B1 (es) *	1999-12-03	2004-05-16	Consejo Superior De Investigaciones Cientificas	Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
WO2001061024A2 (en)	2000-02-16	2001-08-23	Large Scale Biology Corporation	Rolling circle replicon expression vectors
MY146518A (en)	2001-03-27	2012-08-15	Univ Saskatchewan	Methods to culture circovirus.
US7276353B2 (en) *	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en)	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
RU2620968C9 (ru)	2004-12-30	2017-08-08	Берингер Ингельгейм Ветмедика, Инк.	Иммуногенные композиции pcv2 и способы получения таких композиций
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
AU2011253941B2 (en) *	2004-12-30	2015-01-29	Boehringer Ingelheim Animal Health USA Inc.	PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) *	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
ITBO20050123A1 (it)	2005-03-07	2005-06-06	Alfa Wassermann Spa	Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
TW200643171A (en) *	2005-06-07	2006-12-16	Temasek Life Sciences Lab Ltd	Porcine circovirus type 2 vaccines
CN101277717A (zh) *	2005-09-09	2008-10-01	英特威国际有限公司	Pcv-2疫苗
DK2275132T3 (da)	2005-12-29	2021-05-17	Boehringer Ingelheim Animal Health Usa Inc	Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille dem
CA2635430A1 (en)	2005-12-29	2007-08-23	Boehringer Ingelheim Vetmedica, Inc.	Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
WO2008064299A2 (en) *	2006-11-22	2008-05-29	Boehringer Ingelheim Vetmedica, Inc.	Methods of reducing porcine circovirus-associated disease outbreaks
WO2008073464A2 (en)	2006-12-11	2008-06-19	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
PT2094872T (pt) *	2006-12-15	2017-04-27	Boehringer Ingelheim Vetmedica Inc	Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
CN101688185B (zh) *	2007-05-11	2013-05-22	淡马锡生命科学研究院有限公司	对2型猪环状构象病毒(pcv2)感染高度容许的均质细胞系的产生
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
CA2710247C (en) *	2007-12-21	2014-02-18	Wyeth Llc	Methods and compositions for immunizing pigs against porcine circovirus
CN101932336B (zh) *	2007-12-31	2014-07-09	贝林格尔.英格海姆维特梅迪卡有限公司	有外来氨基酸插入的pcv2 orf2病毒样颗粒
KR20100113582A (ko)	2008-01-23	2010-10-21	베링거잉겔하임베트메디카인코퍼레이티드	Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
EP2254595A4 (en) *	2008-02-15	2012-12-05	Boehringer Ingelheim Vetmed	METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES
KR101320192B1 (ko) *	2008-10-16	2013-10-30	조에티스 엘엘씨	토크 테노 바이러스(ｔｔｖ) 분리물 및 조성물
WO2011046634A1 (en) *	2009-10-16	2011-04-21	Pfizer, Inc.	Infectious clones of torque teno virus
US20100150959A1 (en) *	2008-12-15	2010-06-17	Vectogen Pty Ltd.	PCV 2-Based Methods and Compositions for the Treatment of Pigs
TWI627281B (zh)	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
WO2011041796A1 (en)	2009-10-02	2011-04-07	Pioneer Hi-Bred International, Inc.	Down-regulation of acc synthase for improved plant performance
US8846388B2 (en)	2009-10-16	2014-09-30	Zoetis Llc	Infectious clones of torque teno virus
JP2013507944A (ja) *	2009-10-22	2013-03-07	ウニヴェルシテート・ライプツィヒ	汎血球減少症罹患仔ウシにおけるサーコウイルス（ｃｉｒｃｏｖｉｒｕｓ）の特定
US20120100168A1 (en) *	2010-01-25	2012-04-26	Blood Systems, Inc.	Cyclovirus and methods of use
KR20110090711A (ko) *	2010-02-04	2011-08-10	녹십자수의약품(주)	신규한 돼지 써코바이러스 타입 2 및 그의 용도
TWI508974B (zh)	2010-12-22	2015-11-21	Sbc Virbac Ltd	豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
BR112013027860A2 (pt)	2011-04-29	2016-11-29	Pioneer Hi Bred Int	ácido nucleico isolado, planta ou célula vegetal, método para aumentar a capacidade do dreno, acelerar a remobilização e/ou a senescência e a secagem de grão em uma planta, método para aumentar a tolerância a seca na ausência de uma penalidade de produtividade sob condições sem seca, cassete de expressão e método para reduzir a expressão de zmme293 ou a atividade de zmme293 em uma planta
HUP1100470A2 (en)	2011-08-30	2013-03-28	Mezoegazdasagi Biotechnologiai Kutatokoezpont	Nanoparticle-based veterinary vaccine
EP2564869A1 (en)	2011-09-02	2013-03-06	Ceva Sante Animale	Synthetic capsid proteins and uses thereof
UA113192C2 (xx)	2011-12-06	2016-12-26		Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
US9624527B2 (en)	2013-03-01	2017-04-18	Boehringer Ingelheim Vetmedica, Inc.	Quantification of vaccine compositions
KR102217387B1 (ko) *	2013-03-11	2021-02-19	주식회사 중앙백신연구소	재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
EP2789346A1 (en)	2013-04-11	2014-10-15	CEVA Santé Animale SA	Fusion polypeptides and vaccines
EP2994162B1 (en)	2013-05-08	2021-04-07	Pharmgate Biologics Inc.	Vaccine for pcv2 and mycoplasma
CA2925281C (en)	2013-09-25	2022-05-03	Zoetis Services Llc	Pcv2b divergent vaccine composition and methods of use
ES2778425T3 (es)	2013-10-02	2020-08-10	Boehringer Ingelheim Animal Health Usa Inc	Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta
EP3034609A1 (en)	2014-12-19	2016-06-22	Ceva Sante Animale	Recombinant swinepox virus and vaccines
EP3254692A1 (en)	2016-06-10	2017-12-13	Ceva Sante Animale	Multivalent recombinant spv
WO2019032830A1 (en)	2017-08-09	2019-02-14	Dreamwell, Ltd.	ADJUSTABLE SUPPORT STRUCTURE
US20200390878A1 (en)	2017-12-08	2020-12-17	Ceva Sante Animale	Recombinant swinepox virus and vaccines
CN119488586A (zh)	2018-03-26	2025-02-21	勃林格殷格翰动物保健美国有限公司	制备免疫原性组合物的方法
CN112292149A (zh)	2018-06-11	2021-01-29	法国诗华大药厂	针对猪圆环病毒的疫苗接种
WO2022076614A1 (en) *	2020-10-06	2022-04-14	Materials and Machines Corporation of America	Method for detection of rna or dna from biological samples
WO2023192936A2 (en) *	2022-03-30	2023-10-05	Fred Hutchinson Cancer Center	Systems and methods to produce b cells that express selected antibodies and gene products
CN114736310B (zh) *	2022-06-10	2022-10-28	北京华夏兴洋生物科技有限公司	产生圆环病毒2型病毒样颗粒的蛋白质及生物材料与应用
EP4704977A1 (en)	2023-05-03	2026-03-11	Boehringer Ingelheim Vetmedica GmbH	Immunogenic composition useful for self-administration by pigs
AR132582A1 (es)	2023-05-03	2025-07-16	Boehringer Ingelheim Vetmedica Gmbh	Método para inducir una respuesta inmunitaria
WO2026099754A1 (en)	2024-11-06	2026-05-15	Boehringer Ingelheim Vetmedica Gmbh	Method for reducing virus shedding, tissue colonization, and lymphoid depletion caused by or associated with pcv2 infection

Family Cites Families (112)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US69750A (en) *		1867-10-15		Henry bean
US69233A (en) *		1867-09-24		Joseph r
FR2422956A1 (fr)	1978-04-13	1979-11-09	Pasteur Institut	Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
FR2464269B1 (fr)	1979-08-30	1986-04-18	Anvar	Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu
FR2518755B1 (fr)	1981-12-23	1986-04-11	Pasteur Institut	Sonde contenant un acide nucleique modifie et reconnaissable par des anticorps specifiques et utilisation de cette sonde pour detecter et caracteriser une sequence d'adn homologue
US5833975A (en)	1989-03-08	1998-11-10	Virogenetics Corporation	Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US4745051A (en)	1983-05-27	1988-05-17	The Texas A&M University System	Method for producing a recombinant baculovirus expression vector
US5550289A (en)	1985-01-07	1996-08-27	Syntex (U.S.A.) Inc.	N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
US4946787A (en)	1985-01-07	1990-08-07	Syntex (U.S.A.) Inc.	N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5106733A (en)	1987-06-25	1992-04-21	Immunex Corporation	Bovine granulocyte-macrophage colony stimulating factor
SU1538305A1 (ru)	1987-07-21	1994-12-15	Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Госагропрома СССР	Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
US5069901A (en)	1988-02-03	1991-12-03	Jones Elaine V	Preparation of a recombinant subunit vaccine against pseudorabies infection
DE69027112T2 (de)	1989-01-23	1997-01-09	Auspharm International Ltd 4Th	Impfstoffzusammensetzung
US5811103A (en)	1989-03-19	1998-09-22	Akzo Nobel N.V.	Hog cholera virus vaccine and diagnostic
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
DK0737750T3 (da)	1989-03-21	2003-09-01	Vical Inc	Ekspression af exogene polynucleotidsekvenser i vertebrater
US5800992A (en)	1989-06-07	1998-09-01	Fodor; Stephen P.A.	Method of detecting nucleic acids
US5264618A (en)	1990-04-19	1993-11-23	Vical, Inc.	Cationic lipids for intracellular delivery of biologically active molecules
AU657907B2 (en)	1990-05-29	1995-03-30	Wyeth Holdings Corporation	Mycoplasma hyopneumoniae vaccine
US5565205A (en)	1990-08-16	1996-10-15	Solvay Animal Health, Inc.	Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
WO1992005255A1 (en)	1990-09-13	1992-04-02	Commonwealth Scientific And Industrial Research Organisation	Ovine cytokine genes
GB9023111D0 (en)	1990-10-24	1990-12-05	Wellcome Found	Expression system
WO1992007934A1 (en)	1990-11-01	1992-05-14	Iowa State University Research Foundation, Inc.	Bacterial attenuation method and vaccine
EP0575491B1 (en)	1991-03-07	2003-08-13	Virogenetics Corporation	Genetically engineered vaccine strain
ES2026827A6 (es)	1991-03-26	1992-05-01	Ercros Sa	Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
US5580557A (en)	1991-10-09	1996-12-03	Iowa State University Research Foundation, Inc.	Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals
US5382425A (en)	1992-01-13	1995-01-17	Syntro Corporation	Recombinant swinepox virus
US6033904A (en)	1992-01-13	2000-03-07	Syntro Corporation	Recombinant swinepox virus
US5338543A (en)	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
MX9304089A (es)	1992-07-08	1994-01-31	Schering Corp	Uso de gm-csf como una vacuna adyuvante.
JP3149116B2 (ja) *	1992-10-28	2001-03-26	信越化学工業株式会社	ヒトパルボウイルスのエピトープ関連ペプチド
DE69333610D1 (de) *	1992-11-09	2004-10-07	Zonagen Inc	Methoden für die immunoempfängnisverhütung
PL178609B1 (pl)	1993-02-08	2000-05-31	Bayer Ag	Izolat wirusa zespołu reprodukcyjnego i oddechowego świń zwanego PRRSV, sposób namnażania izolatu PRRSV, klon linii komórkowej, hodowla tkankowa zawierająca izolat PRRSV, szczepionka efektywna w ochronie świń przeciw PRRSV oraz sposób wytwarzania szczepionki efektywnej w ochronie świń przeciw PRRSV
EP0620277A1 (en)	1993-03-18	1994-10-19	Merck & Co. Inc.	Nucleic acid pharmaceuticals
AU6672994A (en)	1993-05-14	1994-12-12	Mds Health Group Ltd.	Electronic worksheet system for microbiology testing and reporting
JPH09500013A (ja)	1993-06-01	1997-01-07	ライフ・テクノロジーズ・インコーポレイテッド	カチオン性脂質による遺伝子免疫
JP3626187B2 (ja)	1993-06-07	2005-03-02	バイカルインコーポレイテッド	遺伝子治療に適するプラスミド
US6015686A (en)	1993-09-15	2000-01-18	Chiron Viagene, Inc.	Eukaryotic layered vector initiation systems
FR2711670B1 (fr)	1993-10-22	1996-01-12	Pasteur Institut	Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
GB2285766B (en)	1994-01-21	1997-07-23	Ecc Int Ltd	Ceramic casting composition
KR0121105B1 (ko) *	1994-02-04	1997-11-10	문정환	선입선출메모리 버스장치
EP0804249A2 (en)	1994-03-15	1997-11-05	Brown University Research Foundation	Polymeric gene delivery system
ES2243937T3 (es)	1994-04-29	2005-12-01	Baxter Healthcare S.A.	Poxvirus recombinados en regiones esenciales con la ayuda de polinucleotidos extraños.
EP1820512B1 (en)	1994-05-10	2013-07-03	Boehringer Ingelheim Vetmedica, Inc.	Improved modified live brsv vaccine
DK53595A (da)	1994-05-13	1995-11-14	Iberica Cyanamid	Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner
US5719131A (en)	1994-12-09	1998-02-17	Genzyme Corporation	Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
US5840306A (en) *	1995-03-22	1998-11-24	Merck & Co., Inc.	DNA encoding human papillomavirus type 18
US6043232A (en)	1997-07-23	2000-03-28	Nitromed, Inc.	Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
JPH11504631A (ja)	1995-04-25	1999-04-27	バイカルインコーポレイテッド	Ｄｎａ／脂質複合体の単一バイアル製剤
US5681658A (en) *	1995-05-30	1997-10-28	Aluminum Company Of America	Gelation-resistant alumina
US5885823A (en)	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
WO1996040931A1 (en)	1995-06-07	1996-12-19	Aesculaap B.V.	Neutralizing conformational epitopes of chicken anemia virus
US5705385A (en)	1995-06-07	1998-01-06	Inex Pharmaceuticals Corporation	Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US6019980A (en)	1995-06-07	2000-02-01	Connaught Laboratories Limited	Nucleic acid respiratory syncytial virus vaccines
US5820869A (en)	1995-06-07	1998-10-13	American Home Products Corporation	Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5795872A (en)	1995-09-19	1998-08-18	Pharmadigm, Inc.	DNA construct for immunization
FR2751224B1 (fr)	1996-07-19	1998-11-20	Rhone Merieux	Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
ES2157522T3 (es)	1996-10-09	2001-08-16	Akzo Nobel Nv	Cepas de vacunas europeas del virus del sindrome respiratorio reproductor porcino (prrsv).
WO1998040499A1 (en)	1997-03-10	1998-09-17	Heather Lynn Davis	Gene delivery to mucosal epithelium for immunization or therapeutic purposes
US6004777A (en)	1997-03-12	1999-12-21	Virogenetics Corporation	Vectors having enhanced expression, and methods of making and uses thereof
US5990091A (en)	1997-03-12	1999-11-23	Virogenetics Corporation	Vectors having enhanced expression, and methods of making and uses thereof
US20030215445A1 (en) *	1997-05-23	2003-11-20	Ginette Serrero	Methods and compositions for inhibiting the growth of hematopoietic malignant cells
FR2769321B1 (fr)	1997-10-03	2001-10-26	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
FR2781159B1 (fr)	1998-07-06	2000-10-06	Merial Sas	Vaccin circovirus et parvovirus porcin
US7211379B2 (en)	1997-10-03	2007-05-01	Merial Sas	Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US7192594B2 (en) *	1997-10-03	2007-03-20	Merial Limited	Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
FR2769322B1 (fr)	1997-10-03	2002-03-08	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
US6391314B1 (en)	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
US6143334A (en) *	1997-10-03	2000-11-07	Sargento Foods Inc.	Pasta filata method for manufacturing Swiss-type cheeses
US6517843B1 (en)	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6165493A (en)	1997-10-22	2000-12-26	New York Blood Center, Inc.	"Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US20040062775A1 (en)	1997-12-05	2004-04-01	Agence Francaise De Securite Sanitaire Des Aliments	Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
JP3795751B2 (ja) *	1997-12-11	2006-07-12	ユニバーシティオブサスカッチェワン	ブタからの離乳後多全身系消耗症候群ウイルス
WO1999045956A1 (en) *	1998-03-13	1999-09-16	University Of Georgia Research Foundation, Inc.	Vaccines against circovirus infections
US6294176B1 (en)	1998-07-10	2001-09-25	Schering-Plough Veterinary Corp.	Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
WO2000024428A2 (en)	1998-10-23	2000-05-04	Heska Corporation	Cationic lipid-mediated enhancement of nucleic acid immunization of cats
US6143333A (en)	1998-11-13	2000-11-07	Purina Mills, Inc.	Method of preparing a packaged fish attractant block
FR2789695B1 (fr)	1999-02-11	2003-03-07	Merial Sas	Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6497883B1 (en) *	1999-06-10	2002-12-24	Merial	Porcine circovirus recombinant poxvirus vaccine
US6943152B1 (en)	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
US6139179A (en)	1999-09-03	2000-10-31	Davis-Standard Corporation	Extruder screw having multi-channeled barrier section
US6179461B1 (en)	1999-09-03	2001-01-30	Davis-Standard Corporation	Extruder screw
GB9921147D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
GB9921146D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
WO2001017556A1 (fr)	1999-09-07	2001-03-15	Shionogi & Co., Ltd.	Préparations vaccinales administrables par les muqueuses
DE50009644D1 (de) *	1999-11-10	2005-04-07	Rodenstock Gmbh	Heterocyclisch annellierte indenochromenderivate
US6366601B1 (en) *	1999-11-17	2002-04-02	Motorola, Inc.	Variable rate spread spectrum communication method and apparatus
US7233407B1 (en) *	2000-02-02	2007-06-19	Xerox Corporation	Document production system for capturing web page content
JP3363419B2 (ja) *	1999-12-24	2003-01-08	住友ゴム工業株式会社	重荷重用ラジアルタイヤ
WO2001096377A2 (en)	2000-06-15	2001-12-20	Purdue Research Foundation	Vaccine for congenital tremors in pigs
JP4768106B2 (ja)	2000-07-31	2011-09-07	スリーエムイノベイティブプロパティズカンパニー	接着剤組成物及び熱剥離容易な接着構造
DE10044646A1 (de)	2000-09-08	2002-04-04	Horsch Maschinen Gmbh	Spritzgestängeführung
DE10044648A1 (de) *	2000-09-08	2002-03-21	Aventis Behring Gmbh	Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
DE10051562A1 (de) *	2000-10-18	2002-04-25	Emitec Emissionstechnologie	Beheizbarer Wabenkörper mit zwei verschiedenen Beschichtungen
US6572081B2 (en) *	2000-12-27	2003-06-03	Nkf Kabel B.V.	Installation of guide tubes in a protective duct
MY146518A (en) *	2001-03-27	2012-08-15	Univ Saskatchewan	Methods to culture circovirus.
AUPR567401A0 (en)	2001-06-14	2001-07-12	University Of Melbourne, The	Circovirus vaccines
US7279166B2 (en)	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en)	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US20030215455A1 (en)	2002-05-14	2003-11-20	Bailey Reynolds	Vaccine stabilizer and method of use
AU2002347147A1 (en) *	2002-11-28	2004-06-18	Research In Motion Limited	Multiple-band antenna with patch and slot structures
US7288529B2 (en) *	2003-04-24	2007-10-30	New York University	ALK protein tyrosine kinase, cells and methods embodying and using same
CA2533559C (en)	2003-07-25	2013-07-02	Boehringer Ingelheim Vetmedica, Inc.	Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
US20050279889A1 (en)	2004-06-08	2005-12-22	Safe Flight Instrument Corporation	Variable wing spacecraft
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
CA2587321A1 (en)	2005-01-13	2006-07-20	Boehringer Ingelheim Vetmedica Gmbh	Improved prrs vaccines
MX2007012786A (es)	2005-04-13	2008-01-11	Merial Ltd	Ensayo para produccion de circovirus porcino.
CA2635430A1 (en)	2005-12-29	2007-08-23	Boehringer Ingelheim Vetmedica, Inc.	Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
US8377070B2 (en) *	2007-05-17	2013-02-19	Michael T. Gauthier	Compressor distractor tool
US8214576B2 (en)	2009-03-03	2012-07-03	Vmware, Inc.	Zero copy transport for target based storage virtual appliances

1997
- 1997-12-05 FR FR9715396A patent/FR2772047B1/fr not_active Expired - Lifetime
1998
- 1998-12-04 DK DK08154912.3T patent/DK2000535T3/da active
- 1998-12-04 AU AU14916/99A patent/AU1491699A/en not_active Abandoned
- 1998-12-04 ES ES08154912.3T patent/ES2456959T3/es not_active Expired - Lifetime
- 1998-12-04 DK DK98958957.7T patent/DK1036180T4/da active
- 1998-12-04 WO PCT/FR1998/002634 patent/WO1999029871A2/fr not_active Ceased
- 1998-12-04 EP EP10184556.8A patent/EP2316925B1/fr not_active Expired - Lifetime
- 1998-12-04 PT PT98958957T patent/PT1036180E/pt unknown
- 1998-12-04 PT PT101846269T patent/PT2330188E/pt unknown
- 1998-12-04 EP EP10184626.9A patent/EP2330188B1/fr not_active Expired - Lifetime
- 1998-12-04 ES ES10184556.8T patent/ES2548145T3/es not_active Expired - Lifetime
- 1998-12-04 ES ES08154913.1T patent/ES2458309T3/es not_active Expired - Lifetime
- 1998-12-04 EP EP15172572.8A patent/EP3002331A1/fr not_active Withdrawn
- 1998-12-04 DE DE69840174T patent/DE69840174D1/de not_active Expired - Lifetime
- 1998-12-04 EP EP08154912.3A patent/EP2000535B1/fr not_active Expired - Lifetime
- 1998-12-04 PT PT81549123T patent/PT2000535E/pt unknown
- 1998-12-04 ES ES10184626.9T patent/ES2548146T3/es not_active Expired - Lifetime
- 1998-12-04 PT PT81549131T patent/PT1992696E/pt unknown
- 1998-12-04 ES ES98958957T patent/ES2317679T5/es not_active Expired - Lifetime
- 1998-12-04 AT AT98958957T patent/ATE412664T1/de active
- 1998-12-04 EP EP98958957A patent/EP1036180B2/fr not_active Expired - Lifetime
- 1998-12-04 EP EP08154913.1A patent/EP1992696B1/fr not_active Revoked
- 1998-12-04 DK DK10184556.8T patent/DK2316925T3/da active
- 1998-12-04 DK DK08154913.1T patent/DK1992696T3/da active
- 1998-12-04 DK DK10184626.9T patent/DK2330188T3/da active
- 1998-12-04 PT PT101845568T patent/PT2316925E/pt unknown
2000
- 2000-02-28 US US09/514,245 patent/US6703023B1/en not_active Expired - Lifetime
2003
- 2003-04-09 US US10/409,613 patent/US20040076635A1/en not_active Abandoned
- 2003-05-21 US US10/442,180 patent/US20040091502A1/en not_active Abandoned
- 2003-08-08 US US10/637,011 patent/US7223594B2/en not_active Expired - Lifetime
- 2003-11-21 US US10/718,266 patent/US7148015B2/en not_active Expired - Lifetime
- 2003-11-21 US US10/718,264 patent/US7179472B2/en not_active Expired - Lifetime
2004
- 2004-02-11 US US10/775,337 patent/US20050008651A1/en not_active Abandoned
2005
- 2005-07-08 US US11/176,667 patent/US7244433B2/en not_active Expired - Lifetime
- 2005-10-31 US US11/262,514 patent/US7261898B2/en not_active Expired - Lifetime
2006
- 2006-07-17 US US11/487,589 patent/US7407803B2/en not_active Expired - Fee Related
- 2006-07-19 US US11/488,885 patent/US7297537B2/en not_active Expired - Fee Related
- 2006-07-19 US US11/488,926 patent/US7405075B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,237 patent/US7722883B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,291 patent/US7740865B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,302 patent/US7390494B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,305 patent/US7323330B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,306 patent/US7425444B2/en not_active Expired - Fee Related
2007
- 2007-11-01 US US11/979,296 patent/US7740866B2/en not_active Expired - Fee Related
- 2007-12-20 US US12/003,188 patent/US7741026B2/en not_active Expired - Fee Related
- 2007-12-28 US US12/003,558 patent/US7604808B2/en not_active Expired - Fee Related
2008
- 2008-07-03 US US12/216,410 patent/US7758865B2/en not_active Expired - Fee Related
- 2008-07-28 US US12/219,774 patent/US8715690B2/en not_active Expired - Fee Related
2009
- 2009-09-17 US US12/561,946 patent/US20100226934A1/en not_active Abandoned
- 2009-09-17 US US12/561,829 patent/US20100166791A1/en not_active Abandoned
- 2009-09-17 US US12/561,881 patent/US20100172924A1/en not_active Abandoned
- 2009-10-19 US US12/588,526 patent/US20110135677A1/en not_active Abandoned
- 2009-10-19 US US12/588,525 patent/US20110033489A1/en not_active Abandoned
- 2009-11-13 US US12/618,485 patent/US7951907B2/en not_active Expired - Fee Related
- 2009-12-11 US US12/636,180 patent/US20100215690A1/en not_active Abandoned
2010
- 2010-01-08 US US12/684,506 patent/US20100203072A1/en not_active Abandoned
- 2010-01-11 US US12/685,243 patent/US20100221276A1/en not_active Abandoned
- 2010-03-05 US US12/718,197 patent/US8124723B2/en not_active Expired - Fee Related
- 2010-03-05 US US12/718,153 patent/US20100189732A1/en not_active Abandoned
- 2010-03-05 US US12/718,214 patent/US20100189743A1/en not_active Abandoned
- 2010-03-05 US US12/718,158 patent/US20100189733A1/en not_active Abandoned
- 2010-03-05 US US12/718,168 patent/US20100189734A1/en not_active Abandoned
- 2010-03-05 US US12/718,183 patent/US20100189735A1/en not_active Abandoned
- 2010-04-28 US US12/768,897 patent/US20100209453A1/en not_active Abandoned
2011
- 2011-09-06 US US13/226,013 patent/US8415525B2/en not_active Expired - Fee Related
- 2011-10-20 US US13/277,582 patent/US8916353B2/en not_active Expired - Fee Related
2014
- 2014-04-11 CY CY20141100270T patent/CY1115405T1/el unknown
- 2014-05-05 CY CY20141100318T patent/CY1115424T1/el unknown
- 2014-08-14 NL NL300686C patent/NL300686I2/nl unknown
- 2014-08-14 BE BE2014C049C patent/BE2014C049I2/fr unknown
- 2014-08-14 NL NL300685C patent/NL300685I2/nl unknown
- 2014-08-14 BE BE2014C050C patent/BE2014C050I2/fr unknown
- 2014-08-18 LU LU92523C patent/LU92523I2/xx unknown
- 2014-08-18 LU LU92524C patent/LU92524I2/xx unknown
- 2014-08-19 FR FR14C0062C patent/FR14C0062I2/fr active Active
- 2014-08-19 CY CY2014036C patent/CY2014036I1/el unknown
- 2014-08-19 FR FR14C0061C patent/FR14C0061I2/fr active Active
- 2014-08-19 CY CY2014035C patent/CY2014035I1/el unknown
- 2014-11-14 US US14/541,516 patent/US9700613B2/en not_active Expired - Fee Related
- 2014-11-14 US US14/541,268 patent/US9717784B2/en not_active Expired - Fee Related
2015
- 2015-09-30 CY CY20151100872T patent/CY1116761T1/el unknown
- 2015-10-09 CY CY20151100916T patent/CY1116837T1/el unknown
2016
- 2016-09-07 HK HK16110634.3A patent/HK1222415A1/zh unknown
2017
- 2017-07-28 US US15/662,772 patent/US10052375B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20100215690A1 (en)	2010-08-26
US20100221276A1 (en)	2010-09-02
US20070065925A1 (en)	2007-03-22
US7758865B2 (en)	2010-07-20
US20070110767A1 (en)	2007-05-17
US20040161410A1 (en)	2004-08-19
US8124723B2 (en)	2012-02-28
PT2000535E (pt)	2014-05-02
DK2000535T3 (da)	2014-04-22
US20100189732A1 (en)	2010-07-29
CY1115424T1 (el)	2016-04-13
EP2000535A1 (fr)	2008-12-10
ES2458309T3 (es)	2014-04-30
PT2330188E (pt)	2015-10-23
EP2316925B1 (fr)	2015-07-08
US20070048780A1 (en)	2007-03-01
US20060083756A1 (en)	2006-04-20
US20100203072A1 (en)	2010-08-12
US20060222663A1 (en)	2006-10-05
EP1992696B1 (fr)	2014-02-19
US7244433B2 (en)	2007-07-17
US20100172924A1 (en)	2010-07-08
ES2548146T3 (es)	2015-10-14
US20070253971A1 (en)	2007-11-01
FR2772047A1 (fr)	1999-06-11
US20120034630A1 (en)	2012-02-09
HK1126522A1 (en)	2009-09-04
US6703023B1 (en)	2004-03-09
ES2548145T3 (es)	2015-10-14
HK1222415A1 (zh)	2017-06-30
NL300685I2 (nl)	2022-03-22
FR2772047B1 (fr)	2004-04-09
HK1158254A1 (en)	2012-07-13
NL300686I1 (da)	2014-08-27
PT2316925E (pt)	2015-10-23
US20050008651A1 (en)	2005-01-13
CY2014036I2 (el)	2016-04-13
CY1116761T1 (el)	2017-03-15
DK2316925T3 (da)	2015-10-12
CY2014035I2 (el)	2016-04-13
US7425444B2 (en)	2008-09-16
DE69840174D1 (de)	2008-12-11
ES2456959T3 (es)	2014-04-24
US20110135677A1 (en)	2011-06-09
EP1036180A2 (fr)	2000-09-20
CY1116837T1 (el)	2017-03-15
LU92524I2 (fr)	2014-10-20
PT1992696E (pt)	2014-05-27
US7390494B2 (en)	2008-06-24
US7604808B2 (en)	2009-10-20
FR14C0062I1 (da)	2014-10-10
US7323330B2 (en)	2008-01-29
US20070059324A1 (en)	2007-03-15
US20110033489A1 (en)	2011-02-10
CY1115405T1 (el)	2017-01-04
US20070041989A1 (en)	2007-02-22
US20090092627A1 (en)	2009-04-09
DK2330188T3 (da)	2015-10-19
US7261898B2 (en)	2007-08-28
US7407803B2 (en)	2008-08-05
ATE412664T1 (de)	2008-11-15
DK1036180T3 (da)	2009-03-09
US20100189733A1 (en)	2010-07-29
FR14C0061I1 (da)	2014-10-10
US20100209453A1 (en)	2010-08-19
PT1036180E (pt)	2009-02-10
EP3002331A1 (fr)	2016-04-06
US20040265848A1 (en)	2004-12-30
US20180000927A1 (en)	2018-01-04
BE2014C049I2 (en)	2018-07-04
US7179472B2 (en)	2007-02-20
EP1992696A1 (fr)	2008-11-19
US20050084497A1 (en)	2005-04-21
US20100189734A1 (en)	2010-07-29
US7722883B2 (en)	2010-05-25
US20040076635A1 (en)	2004-04-22
US7740866B2 (en)	2010-06-22
US20070059325A1 (en)	2007-03-15
US20040091502A1 (en)	2004-05-13
NL300685I1 (da)	2014-08-27
WO1999029871A3 (fr)	1999-08-19
EP2000535B1 (fr)	2014-01-22
FR14C0061I2 (fr)	2016-06-24
US20100189743A1 (en)	2010-07-29
HK1125676A1 (en)	2009-08-14
US9700613B2 (en)	2017-07-11
US7148015B2 (en)	2006-12-12
AU1491699A (en)	1999-06-28
US20150175668A1 (en)	2015-06-25
CY2014035I1 (el)	2016-04-13
US20100221283A1 (en)	2010-09-02
US7297537B2 (en)	2007-11-20
US20070041990A1 (en)	2007-02-22
US7740865B2 (en)	2010-06-22
US7223594B2 (en)	2007-05-29
US20150182616A1 (en)	2015-07-02
US8715690B2 (en)	2014-05-06
US20100189736A1 (en)	2010-07-29
CY2014036I1 (el)	2016-04-13
FR14C0062I2 (fr)	2016-06-24
EP1036180B1 (fr)	2008-10-29
US20100189735A1 (en)	2010-07-29
EP2316925A1 (fr)	2011-05-04
US7951907B2 (en)	2011-05-31
NL300686I2 (nl)	2022-03-22
EP2330188A1 (fr)	2011-06-08
US8415525B2 (en)	2013-04-09
US20120005768A1 (en)	2012-01-05
US10052375B2 (en)	2018-08-21
WO1999029871A2 (fr)	1999-06-17
DK1992696T3 (da)	2014-05-19
US9717784B2 (en)	2017-08-01
LU92523I2 (fr)	2014-10-20
ES2317679T3 (es)	2009-04-16
ES2317679T5 (es)	2012-02-24
US20090162918A1 (en)	2009-06-25
US20090123490A1 (en)	2009-05-14
US8916353B2 (en)	2014-12-23
US20100166791A1 (en)	2010-07-01
HK1158694A1 (en)	2012-07-20
EP1036180B2 (fr)	2011-11-02
US20100074919A1 (en)	2010-03-25
US7741026B2 (en)	2010-06-22
US20080233147A1 (en)	2008-09-25
EP2330188B1 (fr)	2015-07-15
US20100226934A1 (en)	2010-09-09
DK1036180T4 (da)	2012-01-23
US7405075B2 (en)	2008-07-29

Publication	Publication Date	Title
BE2014C049I2 (en)	2018-07-04	Circovirus sequences associated with piglet weight loss disease (PWD)
Ridpath et al.	1994	Segregation of bovine viral diarrhea virus into genotypes
DE69526973T2 (de)	2003-01-02	Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
DE69033425T3 (de)	2010-02-18	HCV-Isolat J-1
CA2005291A1 (en)	1990-06-30	Feline infectious peritonitis virus diagnostic tools
EP1167542A3 (en)	2003-12-17	Probe for diagnosing infectious disease arising from Enterococcus faecalis
CA2108466A1 (en)	1992-11-09	Hcv genomic sequences for diagnostics and therapeutics
CA2196555A1 (en)	1996-02-15	Vr-2332 viral nucleotide sequence and methods of use
ATE366314T1 (de)	2007-07-15	Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
EP1197568A3 (en)	2004-04-14	Detection and typing of HCV using 5'UTR and NS5 nucleic acid sequences
CA2193365A1 (en)	1996-01-11	Polynucleotide vaccine for papillomavirus
DE59915205D1 (de)	2010-10-28	Strukturprotein von AAV, seine Herstellung und Verwendung
ATE420190T1 (de)	2009-01-15	Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
Odemuyiwa et al.	2000	An outbreak of African swine fever in Nigeria: virus isolation and molecular characterization of the VP72 gene of a first isolate from West Africa
CA2045323A1 (en)	1991-12-26	Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide
CA2215328A1 (en)	1996-10-03	Novel human cytomegalovirus dna sequences
EP0297378A3 (de)	1989-05-10	2,5-Dihydropyrrole
WO1999058639A3 (en)	1999-12-29	Structural proteins of fish pancreatic disease virus and uses thereof
Banks	1993	DNA restriction fragment length polymorphism among British isolates of Aujeszky's disease virus: use of the polymerase chain reaction to discriminate among strains
AU4136797A (en)	1998-04-02	Novel semaphorin gene: semaphorin y
WO1999004029A3 (en)	1999-04-01	A swine hepatitis e virus and uses thereof
Osterrieder et al.	1994	Expression of equine herpesvirus type 1 glycoprotein gp14 in Escherichia coli and in insect cells: a comparative study on protein processing and humoral immune responses
WO2000028039A3 (en)	2000-10-05	Identification of senv genotypes
CA2198743A1 (en)	1996-03-07	Feline infectious peritonitis vaccine
ATE124991T1 (de)	1995-07-15	Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine.